Previous close | 44.58 |
Open | 44.43 |
Bid | 51.85 |
Ask | 52.85 |
Strike | 190.00 |
Expiry date | 2024-01-19 |
Day's range | 44.43 - 44.58 |
Contract range | N/A |
Volume | |
Open interest | N/A |
There's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.